[Amphotericin B. Lipid complex versus liposomes. Which, why, when?].
Pahissa
A
A
D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001682:Biological Availability; D004337:Drug Carriers; D004655:Emulsions; D006801:Humans; D008081:Liposomes; D009181:Mycoses / Q000188:drug therapy; D013535:Suspensions
D000935:Antifungal Agents; D004337:Drug Carriers; D004655:Emulsions; D008081:Liposomes; D013535:Suspensions; D000666:Amphotericin B
Amfotericina B. Complejo lipídico versus liposómica. Cuál, porqué, cuándo?